SYY
47
-2
QRVO
4
-2
AVGO
35
-2
LRCX
46
-2
CSX
68
3
TXN
49
-6
MA
67
-5
MS
80
-3
EFX
41
-2
PM
58
2
QCOM
55
-2
HRL
30
-3
INTC
49
16
SLG
62
-4
EXR
59
4
KEY
46
-2
AMAT
43
-5
RSG
77
4
FOX
57
-3
NOC
40
-10
SYY
47
-2
QRVO
4
-2
AVGO
35
-2
LRCX
46
-2
CSX
68
3
TXN
49
-6
MA
67
-5
MS
80
-3
EFX
41
-2
PM
58
2
QCOM
55
-2
HRL
30
-3
INTC
49
16
SLG
62
-4
EXR
59
4
KEY
46
-2
AMAT
43
-5
RSG
77
4
FOX
57
-3
NOC
40
-10
Financhill
Back

Arbutus Biopharma Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
41

ABUS
Arbutus Biopharma

Last Price:
3.63
Seasonality Move:
13.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Arbutus Biopharma Price Quote

$3.63
-0.02 (-0.55%)
(Updated: November 14, 2024 at 5:00 PM ET)

Arbutus Biopharma Key Stats

Sell
41
Arbutus Biopharma (ABUS) is a Sell
Day range:
$3.65 - $3.76
52-week range:
$1.75 - $4.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
97.62
P/B ratio:
6.47%
Volume:
651.9K
Avg. volume:
818.6K
1-year change:
103.91%
Market cap:
$691.6M
Revenue:
$18.1M
EPS:
$-0.43

How Much Does Arbutus Biopharma Make?

Is Arbutus Biopharma Growing As A Company?

  • What Is Arbutus Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.71%
  • What Is Arbutus Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arbutus Biopharma Stock Price Performance

  • Did Arbutus Biopharma Stock Go Up Last Month?
    Arbutus Biopharma share price went down by -5.93% last month
  • Did ABUS's Share Price Rise Over The Last Year?
    ABUS share price rose by 103.91% over the past 1 year

What Is Arbutus Biopharma 52-Week High & Low?

Arbutus Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arbutus Biopharma?

  • How Much Debt Does Arbutus Biopharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arbutus Biopharma Have?
    Cash and short term investments quarterly total is $127.8M
  • What Is Arbutus Biopharma’s Book Value Per Share?
    Book value per share is 0.56

Is Arbutus Biopharma Cash Flow Positive?

  • What Is ABUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.8M
  • What Is Arbutus Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.4M
  • What Is Arbutus Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $31.8M

Arbutus Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ABUS return on invested capital is -67.36%
  • What Is Arbutus Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -50.88%
  • What Is ABUS Return On Equity?
    ROE is a measure of profitability and is -67.36%

Arbutus Biopharma Earnings Date & Stock Price

Arbutus Biopharma Competitors

  • Who Are Arbutus Biopharma's Competitors?
    Below is a list of companies who compete with Arbutus Biopharma or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • Amicus Therapeutics Inc (FOLD)
    • GlycoMimetics Inc (GLYC)
    • Ionis Pharmaceuticals Inc (IONS)

Arbutus Biopharma Dividend Yield

Arbutus Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.95%
Revenue: -71.25% -28.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 5.09
Upside from Last Price: 39.47%

Major Shareholders

  • How many ABUS shares are owned by institutional investors?
    162.9M ABUS shares are owned by institutional investors
  • How many ABUS shares are owned by insiders?
    6.8M ABUS shares are owned by insiders